1. Home
  2. ZVIA vs PYPD Comparison

ZVIA vs PYPD Comparison

Compare ZVIA & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zevia PBC

ZVIA

Zevia PBC

N/A

Current Price

$0.94

Market Cap

126.3M

ML Signal

N/A

Logo PolyPid Ltd.

PYPD

PolyPid Ltd.

N/A

Current Price

$6.58

Market Cap

107.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ZVIA
PYPD
Founded
2007
2008
Country
United States
Israel
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Medical/Dental Instruments
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
126.3M
107.0M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
ZVIA
PYPD
Price
$0.94
$6.58
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
5
Target Price
$3.67
★ $11.50
AVG Volume (30 Days)
★ 451.5K
193.8K
Earning Date
11-04-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 55.88
N/A
EPS
N/A
★ N/A
Revenue
★ $161,259,000.00
N/A
Revenue This Year
$9.55
N/A
Revenue Next Year
$6.45
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 4.01
N/A
52 Week Low
$0.96
$3.50
52 Week High
$2.75
$7.15

Technical Indicators

Market Signals
Indicator
ZVIA
PYPD
Relative Strength Index (RSI) 36.32 66.10
Support Level N/A $4.26
Resistance Level $1.52 $7.15
Average True Range (ATR) 0.13 0.52
MACD -0.03 0.05
Stochastic Oscillator 0.53 62.63

Price Performance

Historical Comparison
ZVIA
PYPD

About ZVIA Zevia PBC

Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Share on Social Networks: